Monthly Archives: December 2019

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of AquaVenture Holdings Limited to Culligan is Fair to Shareholders

NEW YORK, NY / ACCESSWIRE / December 27, 2019 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased AquaVenture Holdings Limited ("AquaVenture" or the "Company") (NYSE:WAAS) stock prior to December 23, 2019.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of AquaVenture to Culligan. Under the terms of the agreement, AquaVenture shareholders to receive $27.10 per share in cash. To learn more about the action and your rights, go to:

https://www.zlk.com/mna/aquaventure-holdings-limited

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

The AquaVenture merger investigation concerns whether the Board of AquaVenture breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction and whether Culligan is underpaying for AquaVenture shares, thus unlawfully harming AquaVenture shareholders.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 571472

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of UNIT, REZI and HEXO

NEW YORK, NY / ACCESSWIRE / December 27, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Uniti Group Inc. (NASDAQGS: UNIT)
Class Period: April 20, 2015 to February 15, 2019
Lead Plaintiff Deadline: December 30, 2019

According to the complaint, Uniti Group Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Uniti's financial results were not sustainable because its customer Windstream had defaulted on its unsecured notes; and (ii) as a result of the foregoing, Defendants' statements about Uniti's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in UNIT: http://www.kleinstocklaw.com/pslra-1/uniti-group-inc-loss-submission-form?id=5069&from=1

Resideo Technologies, Inc. (NYSE: REZI)
Class Period: October 29, 2018 to October 22, 2019
Lead Plaintiff Deadline: January 7, 2020

The REZI lawsuit alleges Resideo Technologies, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (a) the negative operational effects of the Company's spin-off from Honeywell International Inc. were more substantial and persistent than disclosed and had negatively affected Resideo's product sales, supply chain, and gross margins, putting the Company's FY19 financial forecasts at risk; and (b) as a result of the foregoing, the Company's financial guidance lacked a reasonable basis and the Company was not on track to make its FY19 guidance as claimed.

Learn about your recoverable losses in REZI: http://www.kleinstocklaw.com/pslra-1/resideo-technologies-inc-loss-submission-form?id=5069&from=1

HEXO Corp. (NYSE: HEXO)
Class Period: January 25, 2019 to November 15, 2019
Lead Plaintiff Deadline: January 27, 2020

Throughout the class period, HEXO Corp. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) HEXO's reported inventory was misstated as the Company was failing to write down or write off obsolete product that no longer had value; (2) HEXO was engaging in channel-stuffing in order to inflate its revenue figures and meet or exceed revenue guidance provided to investors; (3) HEXO was cultivating cannabis at its facility in Niagara, Ontario that was not appropriately licensed by Health Canada; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in HEXO: http://www.kleinstocklaw.com/pslra-1/hexo-corp-loss-submission-form?id=5069&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 571470

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BAX, CGC and FCAU

NEW YORK, NY / ACCESSWIRE / December 27, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Baxter International Inc. (NYSE:BAX)
Class Period: February 21, 2019 to October 23, 2019
Lead Plaintiff Deadline: January 24, 2020

According to the complaint, Baxter International Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) certain intra-Company transactions, undertaken for the purpose of generating foreign exchange gains and losses, used foreign exchange rate conventions that were not in accordance with GAAP and enabled intra-Company transactions to be undertaken after the related exchange rates were already known; (2) the Company lacked effective internal control over financial reporting; (3) as a result, the Company's financial statements were misstated and would likely require correction or amendment; (4) due to the Company's internal investigation, Baxter would not be able to file its quarterly report for the period ending September 30, 2019, with the SEC on Form 10-Q in a timely manner; and (5) as a result of the foregoing, Defendants' statements about the Company's business and operations lacked a reasonable basis.

Learn about your recoverable losses in BAX: http://www.kleinstocklaw.com/pslra-1/baxter-international-inc-loss-submission-form?id=5070&from=1

Canopy Growth Corporation (NYSE:CGC)
Class Period: June 21, 2019 to November 13, 2019
Lead Plaintiff Deadline: January 21, 2020

The complaint alleges Canopy Growth Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing weak demand for its softgel and oil products; (2) as a result, the Company would be forced to take a CA$32.7 million restructuring charge due to poor sales, excessive returns, and excess inventory; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in CGC: http://www.kleinstocklaw.com/pslra-1/canopy-growth-corporation-loss-submission-form?id=5070&from=1

Fiat Chrysler Automobiles N.V. (NYSE:FCAU)
Class Period: February 26, 2016 to November 20, 2019
Lead Plaintiff Deadline: January 31, 2020

The FCAU lawsuit alleges Fiat Chrysler Automobiles N.V. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) the Company employed a bribery scheme to obtain favorable terms in its collective bargaining agreement with United Automobile, Aerospace and Agricultural Implement Workers of America; (2) high-ranking Fiat officials were aware of and authorized the scheme; and (3) as a result, Defendants' statements about Fiat's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in FCAU: http://www.kleinstocklaw.com/pslra-1/fiat-chrysler-automobiles-n-v-loss-submission-form?id=5070&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 571471

CLASS ACTION UPDATE for SEE, YJ and AFI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / December 27, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

SEE Shareholders Click Here: https://www.zlk.com/pslra-1/sealed-air-corporation-loss-form?prid=5068&wire=1
YJ Shareholders Click Here: https://www.zlk.com/pslra-1/yunji-inc-loss-form?prid=5068&wire=1
AFI Shareholders Click Here: https://www.zlk.com/pslra-1/armstrong-flooring-inc-loss-form?prid=5068&wire=1

* ADDITIONAL INFORMATION BELOW *

Sealed Air Corporation (NYSE:SEE)

SEE Lawsuit on behalf of: investors who purchased November 5, 2014 – August 6, 2018
Lead Plaintiff Deadline : December 31, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/sealed-air-corporation-loss-form?prid=5068&wire=1

According to the filed complaint, during the class period, Sealed Air Corporation made materially false and/or misleading statements and/or failed to disclose that: (a) Sealed Air had hired its auditor, E&Y, pursuant to a conflicted and improper process and in order to help facilitate defendants' efforts to engage in accounting fraud; (b) Sealed Air's deduction of $1.49 billion in connection with the Settlement was indefensible and done for the improper purpose of artificially inflating the Company's financial results; (c) Sealed Air had artificially inflated its earnings, cash flows, and operating income during the Class Period; (d) as a result of the above, Sealed Air's Class Period financial statements were materially false and misleading and not prepared in conformance with GAAP; and (e) as a result of the above, Sealed Air's statements regarding its financial results, business, and prospects were materially misleading.

Yunji Inc. (NASDAQ:YJ)

YJ Lawsuit on behalf of: investors who purchased on behalf of shareholders who purchased or otherwise acquired Yunji American Depositary Shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's May 2019 initial public offering.
Lead Plaintiff Deadline : January 13, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/yunji-inc-loss-form?prid=5068&wire=1

According to the filed complaint, (1) the Company was shifting certain of its sales to its marketplace platform; (2) this supply chain restructuring was likely to disrupt Yunji's relationships with suppliers; (3) this supply chain restructuring was likely to have an adverse impact on the Company's financial results; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Armstrong Flooring, Inc. (NYSE:AFI)

AFI Lawsuit on behalf of: investors who purchased March 6, 2018 – November 4, 2019
Lead Plaintiff Deadline : January 14, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/armstrong-flooring-inc-loss-form?prid=5068&wire=1

According to the filed complaint, during the class period, Armstrong Flooring, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had engaged in channel stuffing to artificially boost sales; (2) the Company's internal control over inventory levels was not effective; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 571469

CLASS ACTION UPDATE for QUAD, ET and GRUB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / December 27, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

QUAD Shareholders Click Here: https://www.zlk.com/pslra-1/quad-graphics-inc-loss-form?prid=5067&wire=1
ET Shareholders Click Here: https://www.zlk.com/pslra-1/energy-transfer-lp-loss-form?prid=5067&wire=1
GRUB Shareholders Click Here: https://www.zlk.com/pslra-1/grubhub-inc-loss-form?prid=5067&wire=1

* ADDITIONAL INFORMATION BELOW *

Quad/Graphics, Inc. (NYSE:QUAD)

QUAD Lawsuit on behalf of: investors who purchased February 21, 2018 – October 29, 2019
Lead Plaintiff Deadline : January 6, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/quad-graphics-inc-loss-form?prid=5067&wire=1

According to the filed complaint, during the class period, Quad/Graphics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's book business in United States was underperforming; (2) as a result, the Company was likely to divest its book business; (3) the Company was unreasonably vulnerable to decreases in market prices; (4) to remain financially flexible while market prices decreased, the Company was likely to cut its quarterly dividend and expand its cost reduction programs; and (5) as a result of the foregoing, positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Energy Transfer LP (NYSE:ET)

ET Lawsuit on behalf of: investors who purchased February 25, 2017 – November 11, 2019
Lead Plaintiff Deadline : January 21, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/energy-transfer-lp-loss-form?prid=5067&wire=1

According to the filed complaint, during the class period, Energy Transfer LP made materially false and/or misleading statements and/or failed to disclose that: (i) Energy Transfer's permits to conduct the Mariner East pipeline project in Pennsylvania were secured via bribery and/or other improper conduct; (ii) the foregoing misconduct increased the risk that the Partnership and/or certain of its employees would be subject to government and/or regulatory action, thereby depreciating the Partnership's unit value; and (iii) as a result, the Partnership's public statements were materially false and misleading at all relevant times.

Grubhub Inc. (NYSE:GRUB)

GRUB Lawsuit on behalf of: investors who purchased July 30, 2019 – October 28, 2019
Lead Plaintiff Deadline : January 21, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/grubhub-inc-loss-form?prid=5067&wire=1

According to the filed complaint, during the class period, Grubhub Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) customer orders were actually declining, despite the massive investments that the Company had made to spur demand for and use of its platform; (ii) Grubhub's new customer additions were generating significantly lower revenues as compared to historic cohorts because these customers were more prone to using competitor platforms; (iii) Grubhub's vaunted business model under which it secured exclusive partnerships had failed, and Grubhub needed to engage in the same aggressive nonpartnered sales tactics embraced by its competitors to generate significant revenue growth; (iv) Grubhub was required to spend substantial additional capital in order to grow revenues and retain market share in the face of heightened competitive dynamics and market saturation, eviscerating the Company's profitability; and (v) Grubhub was tracking tens of millions of dollars below its revenue and earnings guidance and such guidance lacked any reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 571468

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of WSG, UA and TIGR

NEW YORK, NY / ACCESSWIRE / December 27, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Wanda Sports Group Company Limited (NASDAQ:WSG)

Investors Affected : Wanda Sports' securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Wanda Sports' July 26, 2019 initial public offering.

A class action has commenced on behalf of certain shareholders in Wanda Sports Group Company Limited. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the lack of major sporting events for its Digital, Production, Sports Solutions ("DPSS") and Spectator Sports segments for its second quarter of 2019, ending before the initial public offering, would negatively impact revenue for the second quarter of 2019; (2) Wanda Sports had suffered a year-over-year decrease in revenue in its second quarter ended June 30, 2019 and would for its fiscal year 2019, primarily related to lower reimbursement revenues accounted for in its DPSS segment and lack of Spectator Sport segment offsets; and (3) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/wanda-sports-group-company-limited-loss-submission-form/?id=5066&from=1

Under Armour, Inc. (NYSE:UA)

Investors Affected : August 3, 2016 – November 1, 2019

A class action has commenced on behalf of certain shareholders in Under Armour, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Under Armour shifted sales from quarter to quarter to appear healthier, including to keep pace with their long-running year-over-year 20% net revenue growth; (2) undisclosed to the investing public, the Company had been under investigation by and cooperating with the U.S. Department of Justice and U.S. Securities and Exchange Commission since at least July 2017; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/under-armour-inc-loss-submission-form/?id=5066&from=1

UP Fintech Holding Limited (NASDAQ:TIGR)

Investors Affected : all persons and entities that purchased or otherwise acquired: (a) Fintech American Depository Shares pursuant and/or traceable to the Company's initial public offering conducted on or about March 20, 2019; or (b) Fintech securities between March 20, 2019 and May 16, 2019.

A class action has commenced on behalf of certain shareholders in UP Fintech Holding Limited. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Fintech was experiencing a material decrease in commissions because of a negative trend related to risk-averse investors in the market; (ii) Fintech was unable to absorb costs associated with the rapid growth of its business and its status as a publicly listed company on a U.S. exchange; (iii) Fintech was incurring significant additional expenses related to, inter alia, employee headcount and employee compensation and benefits; (iv) all of the foregoing had led to Fintech significantly increasing operating costs and expenses; and (v) as a result, the documents filed by the Company in connection with the initial public offering were materially false and/or misleading and failed to state information required to be stated therein, and the Company's Class Period statements were likewise materially false and/or misleading.

Shareholders may find more information at https://securitiesclasslaw.com/securities/up-fintech-holding-limited-loss-submission-form/?id=5066&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 571467

Backpacking Equipment Eligible with FSA – Plan 2020 Adventures Now

Getting Ready For 2020 Backpacking Trips by Spending FSA on Useful First Aid Items

Woodbridge, United States – December 27, 2019 /MarketersMedia/

The 2019 Flexible Savings Account (FSA) season is ending on December 31, 2019. Although some companies allow their employees a grace period through March 15, 2020, it’s about time for most employees to check their balances and see how much they have left in their accounts. FSAs can be used towards medical expenses or even the purchase of eligible items like over-the-counter (OTC) medicines and other medical tools such as prescription glasses and crutches.

Apart from these medical items, FSA-enrolled employees can also use their remaining funds to purchase first aid kits. These life-saving packs are particularly useful, especially for those who like to spend their weekends camping and hiking. Since it’s the perfect time to restock on medical supplies, now is the time to plan 2020 backpacking trips.

Leading adventure preparedness retailer, Surviveware, offers several FSA-eligible items that cater to the needs and requirements of outdoor adventure enthusiasts. One of the most sought-after items they offer is the Small First Aid Kit.

Designed to provide unparalleled assistance when outdoor accidents and adventure-related injuries occur, the pack contains assorted medical items and other life-saving essentials. Everything is stored inside its 600D soft-shelled polyester bag. The fabric makes an excellent container for the first aid essentials mainly because of its water-resistant properties. The pack is also malleable and durable, which is perfect for the varying backcountry weather. Since the Small First Aid Kit easily fits into small nooks and spaces, owners don’t have to worry about breakage or storing bulky containers in drawers, glove compartments, and backpacks.

One of the favorite features of this kit is its MOLLE compatible straps. This allows the kit to be attached to any hiking gear or camping bag. Surviveware’s Small First Aid Kit, which is readily available on Amazon Prime, also comes with a loop ring that can be attached to a carabiner and hooked on hiking packs, tents, and other travel gear. This added feature gives kit owners another option for carrying their first aid packs.

Despite its size, the kit holds 100 medical supplies for treating and stabilizing injuries, wounds, sprains, breaks, exposure, splinters, and insect bites. While it already possesses many items, the kit can hold additional supplies such as a tourniquet or an Epi-pen. The kit can also be converted into an EDC by including survival tools such as a fire starter, multi-tool, or rescue knife.

Contributing to the Surviveware Small First Aid Kit’s status as one of the trusted brands of outdoor kit is its organized and labeled compartments. As accidents can happen anytime and anywhere, this compact kit is user-friendly, so that bystanders and first responders can use and navigate the kit efficiently. Moreover, the pack is also included on Amazon’s FSA, and HSA approved list. Thus, customers can simply use their FSA and HSA cards to order it.

Amazon customer Ronald shared his observation regarding this life-saving pack and the customer service that Surviveware has to offer:

“This first aid kit is well organized with labeled sections to make immediate use efficient and easy. The compact size is perfect for a backpack. The follow-up customer service for this company is excellent, and they even included an emergency flashlight to add to my kit. I’m glad I bought this and item, and I wouldn’t hesitate to do business with them again.”

Jumpstart your 2020 backpacking preparations with a Surviveware Small First Aid Kit. Grab your kit right now by clicking here.

Contact Info:
Name: Amanda Condry
Email: Send Email
Organization: Surviveware
Phone: 703-910-5188
Website: https://surviveware.com

Video URL: https://youtu.be/1fqvO3fYc8A

Source URL: https://marketersmedia.com/backpacking-equipment-eligible-with-fsa-plan-2020-adventures-now/88940767

Source: MarketersMedia

Release ID: 88940767

Innovator Preps Nasdaq 100, Russell 2000, MSCI EAFE, and MSCI Emerging Markets Buffer ETF Listings, Announces Upside Cap Ranges for S&P 500 January Series of Defined Outcome Buffer ETFs

ETFs provide upside exposure up to a cap, with defined downside buffer levels over a one-year Outcome Period
Innovator's Defined Outcome ETFs are the subject of a patent application filed with the U.S. Patent and Trademark Office

CHICAGO, IL / ACCESSWIRE / December 27, 2019 / Innovator Capital Management, LLC (Innovator) announced today the anticipated upside cap ranges for the January Series of Innovator S&P 500 Buffer ETFs™, along with four new Power Buffer ETFs scheduled to begin trading on January 2, 2020, based on the Nasdaq 100, Russell 2000, MSCI EAFE, and MSCI Emerging Markets Indexes.

For the remainder of 2019, the January Series of Innovator S&P 500 Buffer ETFs (BJAN, PJAN, UJAN) provide investors an outcome period of less than one week, with known upside potential and downside buffers through year end. Investors who purchase prior to the rebalance on January 2, 2020 will also be fully invested for the new outcome period, obtaining fresh upside caps and downside buffers for the year ahead. Click on the following link for additional information, How to get Invested, Hedged, and Ready for 2020 Today.

Anticipated return profiles for the Innovator S&P 500, Nasdaq 100, Russell 2000, MSCI EAFE, and MSCI Emerging Markets January Series of Buffer ETFs, as of 12/27/19

Ticker

Name

Buffer Level

Cap Range*

Outcome Period

BJAN

Innovator S&P 500
Buffer ETF™

9.00%

12.91 – 14.21%

12 months
1/1/20 – 12/31/20

PJAN

Innovator S&P 500
Power Buffer ETF™

15.00%

8.30 – 9.01%

12 months
1/1/20 – 12/31/20

UJAN

Innovator S&P 500
Ultra Buffer ETF™

30.00%
(-5% to -35%)

7.18 – 7.68%

12 months
1/1/20 – 12/31/20

NJAN

Innovator Nasdaq-100
Power Buffer ETF™

15.00%

9.24 – 10.42%

12 months
1/1/20 – 12/31/20

KJAN

Innovator Russell 2000
Power Buffer ETF™

15.00%

8.72 – 10.38%

12 months
1/1/20 – 12/31/20

IJAN

Innovator MSCI EAFE
Power Buffer ETF™

15.00%

7.90 – 8.55%

12 months
1/1/20 – 12/31/20

EJAN

Innovator MSCI Emerging Markets
Power Buffer ETF™

15.00%

10.18 – 13.19%

12 months
1/1/20 – 12/31/20

* The Cap Ranges above are based on the highest and lowest Cap as illustrated by the Funds' strategy from 11/25/19 – 12/24/19 and are shown gross of the 0.79% management fee for BJAN, PJAN, UJAN, NJAN, KJAN; EJAN's 0.89% management fee, and IJAN's 0.85% management fee. The actual Cap for each Fund will be set at the beginning of the Outcome Period, and is dependent upon market conditions at that time. Periods of high market volatility could result in higher caps, and lower volatility could result in lower caps. As a result, the Cap set by each Fund may be higher or lower than the Cap Range. "Cap" refers to the maximum potential return, before fees and expenses and any shareholder transaction fees and any extraordinary expenses, if held over the full Outcome Period. "Buffer" refers to the amount of downside protection the fund seeks to provide, before fees and expenses, over the full Outcome Period. Outcome Period is the intended length of time over which the defined outcomes are sought. Upon fund launch, the Caps can be found on a daily basis via www.innovatoretfs.com. NJAN, KJAN, IJAN, EJAN are not yet available for investment.

Innovator Defined Outcome ETFsTM seek to provide a defined exposure to a broad market index (such as the S&P 500, Nasdaq 100, Russell 2000, MSCI EAFE, and MSCI Emerging Markets) where the downside buffer level, upside growth potential to a Cap, and Outcome Period are all known, prior to investing. The ETFs reset annually and can be held indefinitely. Innovator Defined Outcome ETFs, with over $1.7 billion in AUM as of December 26, 2019, are among the fastest-growing new categories of ETFs in the market today.

Defined Outcome ETF Webinars and Videos

Innovator is committed to expanding advisor education around Defined Outcome ETF investing, and has produced a series of webinars available for replay posted on its website using the following link: http://www.innovatoretfs.com/webinars.

Listen to the Innovator Defined Outcome ETFs 101 explainer video by clicking here.

The Funds have characteristics unlike many other traditional investment products and may not be suitable for all investors. For more information regarding whether an investment in the Fund is right for you, please see "Investor Suitability" in the prospectus.

The Innovator Defined Outcome Suite of ETFs

S&P 500:

Innovator S&P 500 Buffer ETFs™ (Cboe: BAPR, BJUN, BJUL, BAUG, BSEP, BOCT, BNOV, BDEC, BJAN): Designed to track the price return of the S&P 500 (up to a predetermined Cap) while buffering investors against the first 9% of losses over the Outcome Period, before fees and expenses.

Innovator S&P 500 Power Buffer ETFs™ (Cboe: PAPR, PJUN, PJUL, PAUG, PSEP, POCT, PNOV), PDEC, PJAN): Designed to track the price return of the S&P 500 (up to a predetermined Cap) while buffering investors against the first 15% of losses over the Outcome Period, before fees and expenses.

Innovator S&P 500 Ultra Buffer ETFs™ (Cboe: UAPR, UJUN, UJUL, UAUG, USEP, UOCT, UNOV), UDEC, UJAN): Designed to track the price return of the S&P 500 (up to a predetermined Cap) while buffering investors against a decline of 30% of losses over the Outcome Period, from -5% to -35%, before fees and expenses. Investors are exposed to loss between 0% and 5% and over 35% over the Outcome Period, before fees and expenses.

Nasdaq 100:

Innovator Nasdaq-100 Power Buffer ETF™ (Cboe: NOCT): Designed to track the price return of the Nasdaq 100 Index (up to a predetermined Cap) while buffering investors against the first 15% of losses over the Outcome Period, before fees and expenses.

Russell 2000:

Innovator Russell 2000 Power Buffer ETF™ (Cboe: KOCT): Designed to track the price return of the Russell 2000 Index (up to a predetermined Cap) while buffering investors against the first 15% of losses over the Outcome Period, before fees and expenses.

MSCI EAFE:

Innovator MSCI EAFE Power Buffer ETF™ (NYSE: IJUL): Designed to track the price return of the MSCI EAFE Index (up to a predetermined Cap) while buffering investors against the first 15% of losses over the Outcome Period, before fees and expenses.

MSCI Emerging Markets:

Innovator MSCI Emerging Markets Power Buffer ETF™ (NYSE: EJUL): Designed to track the price return of the MSCI Emerging Markets Index (up to a predetermined Cap) while buffering investors against the first 15% of losses over the Outcome Period, before fees and expenses.

Interim Period Shareholders

Unlike structured notes, which offer limited liquidity, Innovator Defined Outcome ETFs trade throughout the day on an exchange, like a stock. As a result, investors purchasing shares of a Fund after its launch date may achieve a different payoff profile than those who entered the Fund on day one. Innovator recognizes this as a benefit of the Funds and provides a web-based tool that allows investors to know, in real-time throughout the trading day, their potential defined outcome return profile before they invest, based on the current ETF price and the Outcome Period remaining. Innovator's web tool can be accessed at http://www.innovatoretfs.com/define.

About Innovator Defined Outcome ETFs

Each Innovator Defined Outcome ETF seeks to provide a defined exposure to a broad market index (such as the S&P 500, Nasdaq 100, Russell 2000, MSCI EAFE, and MSCI Emerging Markets) where the downside buffer level, upside growth potential to a Cap, and Outcome Period are all known, prior to investing. Innovator is expanding its suite of S&P 500 Buffer ETFs into a monthly series to provide investors more opportunities to purchase shares as close to the beginning of their respective Outcome Periods as possible.

Investors can purchase shares of a previously listed Defined Outcome ETF throughout the entire Outcome Period, obtaining a current set of defined outcome parameters, which are disclosed daily through a web tool available at: http://innovatoretfs.com/define/.

Innovator is focused on delivering defined outcome based solutions inside the benefit-rich ETF wrapper, retaining many of the features that have contributed to the success of structured products1 (e.g., downside buffer levels, upside participation, defined outcome parameters), but with the added benefits of transparency, liquidity and lower costs afforded by the ETF structure.

ETF Construction

Each Fund will hold a portfolio of custom exchange-traded FLEX Options that have varying strike prices (the price at which the option purchaser may buy or sell the security, at the expiration date), and the same expiration date (approximately one year). The layering of these FLEX Options with varying strike prices provides the mechanism for producing a Fund's desired outcome (i.e. Cap or buffer). Each Fund intends to roll options components annually, on the last business day of the month associated with each Fund.

The ETFs are subadvised by Milliman Financial Risk Management LLC (Milliman FRM), a global leader in financial risk management and one of the largest ETF sub advisors. Milliman FRM was also instrumental in the design of the Cboe S&P 500 Target Outcome Indexes, which the Innovator Defined Outcome S&P 500 Buffer ETFs are benchmarked against.

Although each Fund seeks to achieve the defined outcomes stated in its investment objective, there is no guarantee that it will do so. The returns that the Funds seek to provide do not include the costs associated with purchasing shares of the Fund and certain expenses incurred by the Fund.

About Innovator Capital Management, LLC

Innovator Capital Management, LLC is an SEC registered investment advisor (RIA) based in Wheaton, IL. Formed in 2014, the firm is currently headed by ETF visionaries Bruce Bond and John Southard, founders of one of the largest ETF providers in the world. Innovation is our hallmark and acts as a guide to our company principles. Innovator is committed to helping investors better control their financial outcomes by providing investment opportunities they never considered or thought possible. For additional information, visit www.innovatoretfs.com.

About Milliman Financial Risk Management LLC

Milliman Financial Risk Management LLC (Milliman FRM) is a global leader in financial risk management to the retirement industry, providing investment advisory, hedging, and consulting services on over $147.6 billion in global assets as of March 31, 2019. For more information about Milliman FRM, visit Milliman.com/FRM.

About S&P Dow Jones

The Innovator S&P Defined Outcome ETFs Series are based on a license for the use of the relevant S&P 500 indexes and related marks in connection with a defined outcome ETF. The S&P 500 Index is a product of S&P Dow Jones Indices LLC or its affiliates ("SPDJI") and S&P Opco, LLC, and has been licensed for use by Innovator. Standard & Poor's® and S&P® are registered trademarks of Standard & Poor's Financial Services LLC ("S&P"); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC ("Dow Jones"); and these trademarks have been licensed for use by SPJI and sublicensed for certain purposes by Innovator. S&P Opco's trademarks are trademarks of S&P Opco, and have been licensed for use by SPDJI and Innovator. The Innovator ETFs are not sponsored, endorsed, sold, or promoted by SPDJI, Dow Jones, S&P, their respective affiliates, or S&P Opco and none of such parties make any representations regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of the S&P 500 index.

Media Contact
Bill Conboy
+1 (303) 415-2290
bill@bccapitalpartners.com

1 Structured notes and structured annuities are financial instruments designed and created to afford investors exposure to an underlying asset through a derivative contract. It is important to note that these ETFs are not structured notes or structured annuities.

Investing involves risks. Loss of principal is possible. The Funds face numerous market trading risks, including active markets risk, authorized participation concentration risk, buffered loss risk, cap change risk, capped upside return risk, correlation risk, liquidity risk, management risk, market maker risk, market risk, non-diversification risk, operation risk, options risk, trading issues risk, upside participation risk and valuation risk. For a detail list of fund risks see the prospectus.

Foreign and Emerging Markets Risk Non-U.S. securities and Emerging Markets are subject to higher volatility than securities of domestic issuers due to possible adverse political, social or economic developments, restrictions on foreign investment or exchange of securities, lack of liquidity, currency exchange rates, excessive taxation, government seizure of assets, different legal or accounting standards, and less government supervision and regulation of securities exchanges in foreign countries.

Technology Sector Risk Companies in the technology sector are often smaller and can be characterized by relatively higher volatility in price performance when compared to other economic sectors. They can face intense competition which may have an adverse effect on profit margins.

Small Cap Risk Small cap companies may be more volatile and susceptible to adverse developments than their mid and large cap counterpart. In addition, the small cap companies may be less liquid than larger companies.

FLEX Options Risk The Fund will utilize FLEX Options issued and guaranteed for settlement by the Options Clearing Corporation (OCC). In the unlikely event that the OCC becomes insolvent or is otherwise unable to meet its settlement obligations, the Fund could suffer significant losses. Additionally, FLEX Options may be less liquid than standard options. In a less liquid market for the FLEX Options, the Fund may have difficulty closing out certain FLEX Options positions at desired times and prices. The values of FLEX Options do not increase or decrease at the same rate as the reference asset and may vary due to factors other than the price of reference asset.

These Funds are designed to provide point-to-point exposure to the price return of the Index via a basket of Flex Options. As a result, the ETFs are not expected to move directly in line with the Index during the interim period.

Investors purchasing shares after an outcome period has begun may experience very different results than funds' investment objective. Initial outcome periods are approximately 1-year beginning on the funds' inception date. Following the initial outcome period, each subsequent outcome period will begin on the first day of the month the fund was incepted. After the conclusion of an outcome period, another will begin.

Fund shareholders are subject to an upside return cap (the "Cap") that represents the maximum percentage return an investor can achieve from an investment in the funds' for the Outcome Period, before fees and expenses. If the Outcome Period has begun and the Fund has increased in value to a level near to the Cap, an investor purchasing at that price has little or no ability to achieve gains but remains vulnerable to downside risks. Additionally, the Cap may rise or fall from one Outcome Period to the next. The Cap, and the Fund's position relative to it, should be considered before investing in the Fund. The Funds' website, www.innovatoretfs.com, provides important Fund information as well information relating to the potential outcomes of an investment in a Fund on a daily basis.

The Funds only seek to provide shareholders that hold shares for the entire Outcome Period with their respective buffer level against Index losses during the Outcome Period. You will bear all Index losses exceeding 9, 15 or 30%. Depending upon market conditions at the time of purchase, a shareholder that purchases shares after the Outcome Period has begun may also lose their entire investment. For instance, if the Outcome Period has begun and the Fund has decreased in value beyond the pre-determined buffer, an investor purchasing shares at that price may not benefit from the buffer. Similarly, if the Outcome Period has begun and the Fund has increased in value, an investor purchasing shares at that price may not benefit from the buffer until the Fund's value has decreased to its value at the commencement of the Outcome Period.

Nasdaq® is a registered trademark of Nasdaq, Inc. (which with its affiliates is referred to as the "Corporations") and is licensed for use by Innovator Capital Management, LLC. The Product(s) have not been passed on by the Corporations as to their legality or suitability. The Product(s) are not issued, endorsed, sold, or promoted by the Corporations.

THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE PRODUCT(S).

The Innovator Russell 2000 Power Buffer ETF (the "Fund") has been developed solely by Innovator Capital Management, LLC. The "Fund" is not in any way connected to or sponsored, endorsed, sold or promoted by the London Stock Exchange Group plc and its group undertakings (collectively, the "LSE Group"). FTSE Russell is a trading name of certain of the LSE Group companies. All rights in the Russell 2000 Index (the "Index") vest in the relevant LSE Group company which owns the Index. "FTSE®" "Russell®", and "FTSE Russell®" are trade marks of the relevant LSE Group company and are used by any other LSE Group company under license.

The Index is calculated by or on behalf of FTSE International Limited or its affiliate, agent or partner. The LSE Group does not accept any liability whatsoever to any person arising out of (a) the use of, reliance on or any error in the Index or (b) investment in or operation of the Fund. The LSE Group makes no claim, prediction, warranty or representation either as to the results to be obtained from the Fund or the suitability of the Index for the purpose to which it is being put by Innovator Capital Management, LLC.

The ETFs referred to herein is not sponsored, endorsed, or promoted by MSCI Inc. or based upon the MSCI EAFE and MSCI Emerging Markets Indexes. MSCI Inc. bears no liability with respect to the ETFs.

MSCI, MSCI EAFE, and MSCI Emerging Markets are trademarks or service marks of MSCI Inc. or its affiliates ("Marks") and are used hereto subject to license from MSCI. All goodwill and use of Marks inures to the benefit of MSCI and its affiliates. No other use of the Marks is permitted without a license from MSCI.

Cboe Global Markets, Inc., and its affiliates do not recommend or make any representation as to possible Benefits from any securities, futures or investments, or third-party products or services. Cboe Global Markets, Inc., is not affiliated with S&P DJI, Milliman, or Innovator Capital Management. Investors should undertake their own due diligence regarding their securities, futures and investment practices.

Cboe Global Markets, Inc., and its affiliates make no warranty, expressed or implied, including, without limitation, any warranties as of merchantability, fitness for a particular purpose, accuracy, completeness or timeliness, or as to the results to be obtained by recipients of the products.

Innovator ETFsTM, Defined Outcome ETFTM, Buffer ETFTM, Enhanced ETFTM, Define Your FutureTM, Leading the Defined Outcome ETF RevolutionTM and other service marks and trademarks related to these marks are the exclusive property of Innovator Capital Management, LLC.

The Funds' investment objectives, risks, charges and expenses should be considered before investing. The prospectus contains this and other important information, and it may be obtained at innovatoretfs.com. Read it carefully before investing.

Innovator ETFs are distributed by Foreside Fund Services, LLC.

Copyright © 2019 Innovator Capital Management, LLC.

800.208.5212

SOURCE: Innovator

ReleaseID: 571455

Cynthia Telles: Insight on Serving Those in Need

LOS ANGELES, CA / ACCESSWIRE / December 27, 2019 / Working to serve those most in need is part of the core mission of quality health care. In the coming months, Kaiser Permanente will provide more than $40 million in grants to community-based organizations, much of which will help ensure access to health care for uninsured people and under-resourced communities.

"Our commitment to helping underserved communities achieve consistent and positive health outcomes is not only central to how we operate as a nonprofit health provider, but also to our approach to community giving," said Dr. Cynthia Telles, Community Health committee chair for the Kaiser Foundation Health Plan and Hospitals Boards of Directors. "It is part of our mission to improve the health of our communities."

Quarterly grants such as these are part of Kaiser Permanente's yearly contributions to improve access to care in its communities. Since its establishment in 1945, the overarching goal for Kaiser Permanente has always been to provide high quality and affordable care, and to improve the health of the more than 68 million people who live in the communities it serves.

Through her role as Community Health committee chair, Dr. Cynthia Telles has dedicated her focus on expanding access to high-quality physical and mental health care, especially to underserved communities, and offering strategic oversight of the organization's approach to community health.

"We believe everyone should have the ability to access affordable health care," said Dr. Telles. "We support our community members in obtaining the care they need when they need it."

Kaiser Permanente grants provide support where the needs and opportunities for impact are the greatest. Project Access NOW, one of the grant recipients, provides access to donated health care, enrollment in health care coverage options, and access to free or low-cost medications throughout Portland, Oregon.

Other funded organizations and programs include:

Santa Rosa Community Health and its campaign to rebuild a clinic that was destroyed by a wildfire in 2017

Highline Public Schools and their efforts to expand the school system's capacity to deliver mental health support, improve mental health awareness, reduce barriers to accessing school mental health services, and promote staff wellness.

Fresno County of Office Education, which will fund a mobile school-based health clinic for students and families – particularly in rural Fresno County, where access to care is limited or nonexistent.

"I am so proud of Kaiser Permanente's legacy of improving community health, which includes dedicating nearly $2.8 billion to improve health and wellness in communities across the country," said Dr. Cynthia Telles. "In addition to grants, we also serve the community through a range of programs including Medicaid, charitable health coverage, medical financial assistance, and medical research."

For more information about Kaiser Permanente's community health work, review the organization's most recent Community Health Snapshot at https://healthy.kaiserpermanente.org/static/health/annual_reports/chsnapshot2018/ or reach out to John Nelson at John.E.Nelson@kp.org.

SOURCE: Kaiser Permanente

ReleaseID: 571458

TerraX Minerals Inc. Announces Closing of C$5 Million Financing

Not for Distribution to U.S. News Wire Services or Dissemination in the United States.

VANCOUVER, BC / ACCESSWIRE / December 27, 2019 / TerraX Minerals Inc. (TSXV:TXR)(Frankfurt:TX0)(OTCPINK:TRXXF) ("TerraX" or the "Company") is pleased to announce that it has closed its previously announced bought deal financing (the "Offering") for aggregate gross proceeds of C$5 million.

Pursuant to the Offering, a total of 20 million common shares of TerraX ("Common Shares") were sold at a price of C$0.25 per Common Share for gross proceeds of C$5 million. The Offering was made through BMO Capital Markets (the "Underwriter"). The Underwriter received a cash commission equal to 6% of the gross proceeds of the Offering (other than from the issue and sale of the Common Shares to certain purchasers on a president's list, for which a 2% cash commission was paid).

The Company has granted the Underwriter an option (the "Over-Allotment Option"), exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 10% of the number of Common Shares sold under the Offering to cover over-allotments, if any. The Common Shares were sold by way of a short form prospectus in each of the provinces of Canada, excluding Quebec, and were also sold by way of private placement in the United States.

The securities offered have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Concurrent with the completion of the Offering, the Company issued an aggregate of 320,000 Common Shares at a price of C$0.25 per Common Share for aggregate gross proceeds of C$80,000. These shares were issued on a non-brokered private placement basis and are subject to a statutory hold period in Canada expiring on April 28, 2020. No commission or other fees were paid in connection with the issuance of such shares.

The net proceeds of the Offering and the shares issued on a private placement basis will be used to advance exploration at the Company's wholly-owned Yellowknife City Gold project, for working capital, and for general corporate purposes.

About TerraX

Through a series of acquisitions, TerraX owns a 100% interest in the Yellowknife City Gold ("YCG") Project, encompassing 783 sq km of contiguous land within 12 kilometers of the city of Yellowknife. The YCG Project is located in the prolific Yellowknife greenstone belt, covering 70 kilometers of strike length along the main mineralized break in proximity to the former high-grade Con and Giant gold mines which have produced over 14 million ounces of gold. The YCG Project is close to vital infrastructure, including all-season roads, air transportation, service providers, hydro-electric power and skilled tradespeople.

For more information on the YCG project, please visit our web site at www.terraxminerals.com.

On behalf of the Board of Directors,

"DAVID SUDA"

David Suda
President and CEO

For more information, please contact:

Samuel Vella
Manager of Corporate Communications
Phone: 604-689-1749 / Toll-Free: 1-855-737-2684
svella@terraxminerals.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors – including the availability of funds, the results of financing efforts, the completion of due diligence and the results of exploration activities – that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Forward-looking statements in this news release include, but are not limited to, statements regarding the use of proceeds from the Offering and the existence of the Over-Allotment Option which may be exercised by the Underwriter within the next 30 days. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, events or otherwise.

SOURCE: TerraX Minerals Inc.

ReleaseID: 571406